George W. Wright
Molecular Biology · 2002–2020
A researcher in the Science corpus: 16 papers; trusts 11 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 76 citations into it; #4,749 of 17,773 by trust here, #9,851 by citations
Whom George W. Wright trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Yoav Benjamini
- Pierre Baldi
- Andreas Rosenwald
- M. Kerr
- Edward L. Korn
- Y. Hochberg
- Anthony D. Long
- Bar Harbor
- J. Troendle
- Ash A. Alizadeh
Who trusts George W. Wright overall
- Davis J. McCarthy
- Gordon K. Smyth
- Yunshun Chen
- Charity W. Law
- Belinda Phipson
- Michael Romano
- Stanley C Lee
- James A. Hanley
- Jelle J. Goeman
- Kyung In Kim
Papers from George W. Wright's perspective
Ordered by how strongly the researchers George W. Wright trusts endorse each paper. Same corpus, a different order for every researcher.
- Controlling the false discovery rate: a practical and powerful approach to multiple testing
- Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. (Cancer Research)
- c-Myc-regulated microRNAs modulate E2F1 expression (Nature)
- The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. (Blood)
- A loss-of-function RNA interference screen for molecular targets in cancer (Nature)
- Global variation in copy number in the human genome (Nature)
- Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma (Science)
- High-throughput oncogene mutation profiling in human cancer (Nature Genetics)
- Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (Nature Medicine)
- The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. (Cancer Cell)
Their papers
- A random variance model for detection of differential gene expression in small microarray experiments (2003) — 705 citations
- The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. (2003) — 970 citations
- A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications (2020) — 974 citations
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma (2018) — 1,854 citations
- Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma (2015) — 1,094 citations
- Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics (2012) — 975 citations
- Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. (2012) — 1,068 citations
- Chronic Active B Cell Receptor Signaling in Diffuse Large B Cell Lymphoma (2010) — 1,639 citations
- Oncogenically active MYD88 mutations in human lymphoma (2010) — 1,509 citations
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways (2008) — 1,040 citations
- Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma (2008) — 886 citations
- Stromal Gene Signatures in Large-B-Cell Lymphomas (2008) — 1,778 citations
- Molecular diagnosis of Burkitt's lymphoma. (2006) — 1,004 citations
- Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. (2004) — 1,431 citations
- Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma (2003) — 1,127 citations
- The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. (2002) — 3,853 citations